NFATc1 controls the cytotoxicity of CD8+ T cells

被引:0
|
作者
Stefan Klein-Hessling
Khalid Muhammad
Matthias Klein
Tobias Pusch
Ronald Rudolf
Jessica Flöter
Musga Qureischi
Andreas Beilhack
Martin Vaeth
Carsten Kummerow
Christian Backes
Rouven Schoppmeyer
Ulrike Hahn
Markus Hoth
Tobias Bopp
Friederike Berberich-Siebelt
Amiya Patra
Andris Avots
Nora Müller
Almut Schulze
Edgar Serfling
机构
[1] University of Würzburg,Department of Molecular Pathology, Institute of Pathology, and Comprehensive Cancer Center Mainfranken
[2] University of Mainz,Institute for Immunology, University Medical Center
[3] University of Würzburg,Department of Biochemistry and Molecular Biology, Theodor
[4] University Würzburg,Boveri
[5] Saarland University,Institute, Biocenter, and Comprehensive Cancer Center Mainfranken
[6] Saarland University,Department of Medicine II, Würzburg University Hospital, Research Center for Infectious Diseases, and Interdisciplinary Center for Clinical Science Research
[7] University of Würzburg,Department of Biophysics, CIPMM, Faculty of Medicine
[8] New York University School of Medicine,Cellular Neurophysiology, CIPMM
[9] University of Plymouth,Institute for Virology and Immunobiology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cytotoxic T lymphocytes are effector CD8+ T cells that eradicate infected and malignant cells. Here we show that the transcription factor NFATc1 controls the cytotoxicity of mouse cytotoxic T lymphocytes. Activation of Nfatc1−/− cytotoxic T lymphocytes showed a defective cytoskeleton organization and recruitment of cytosolic organelles to immunological synapses. These cells have reduced cytotoxicity against tumor cells, and mice with NFATc1-deficient T cells are defective in controlling Listeria infection. Transcriptome analysis shows diminished RNA levels of numerous genes in Nfatc1−/− CD8+ T cells, including Tbx21, Gzmb and genes encoding cytokines and chemokines, and genes controlling glycolysis. Nfatc1−/−, but not Nfatc2−/− CD8+ T cells have an impaired metabolic switch to glycolysis, which can be restored by IL-2. Genome-wide ChIP-seq shows that NFATc1 binds many genes that control cytotoxic T lymphocyte activity. Together these data indicate that NFATc1 is an important regulator of cytotoxic T lymphocyte effector functions.
引用
收藏
相关论文
共 50 条
  • [1] NFATc1 controls the cytotoxicity of CD8+ T cells
    Klein-Hessling, Stefan
    Muhammad, Khalid
    Klein, Matthias
    Pusch, Tobias
    Rudolf, Ronald
    Floeter, Jessica
    Qureischi, Musga
    Beilhack, Andreas
    Vaeth, Martin
    Kummerow, Carsten
    Backes, Christian
    Schoppmeyer, Rouven
    Hahn, Ulrike
    Hoth, Markus
    Bopp, Tobias
    Berberich-Siebelt, Friederike
    Patra, Amiya
    Avots, Andris
    Mueller, Nora
    Schulze, Almut
    Serfling, Edgar
    NATURE COMMUNICATIONS, 2017, 8
  • [2] Biallelic NFATC1 mutations cause an inborn error of immunity with impaired CD8+ T-cell function and perturbed glycolysis
    Bal, Sevgi Kostel
    Giuliani, Sarah
    Block, Jana
    Repiscak, Peter
    Hafemeister, Christoph
    Shahin, Tala
    Kasap, Nurhan
    Ransmayr, Bernhard
    Miao, Yirun
    van de Wetering, Cheryl
    Frohne, Alexandra
    Heredia, Raul Jimenez
    Schuster, Michael
    Zoghi, Samaneh
    Hertlein, Vanessa
    Thian, Marini
    Bykov, Aleksandr
    Babayeva, Royala
    Eltan, Sevgi Bilgic
    Karakoc-Aydiner, Elif
    Shaw, Lisa E.
    Chowdhury, Iftekhar
    Varjosalo, Markku
    Arguello, Rafael J.
    Farlik, Matthias
    Ozen, Ahmet
    Serfling, Edgar
    Dupre, Loic
    Bock, Christoph
    Halbritter, Florian
    Hannich, J. Thomas
    Castanon, Irinka
    Kraakman, Michael J.
    Baris, Safa
    Boztug, Kaan
    BLOOD, 2023, 142 (09) : 827 - 845
  • [3] Intravenous immunoglobulin modulates the expansion and cytotoxicity of CD8+ T cells
    Trepanier, Patrick
    Chabot, Dominique
    Bazin, Renee
    IMMUNOLOGY, 2014, 141 (02) : 233 - 241
  • [4] Notch controls effector and memory differentiation of CD8+ T cells
    Backer, R. A.
    Helbig, C.
    Eldering, E.
    Kerhoven, R. M.
    van Kampen, A. H. C.
    ten Brinke, A.
    Gisbergen, K. P. J. M.
    Amsen, D.
    IMMUNOLOGY, 2012, 137 : 135 - 136
  • [5] Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation
    Ye, Zhenmin
    Tang, Chaoke
    Xu, Shulin
    Zhang, Bei
    Zhang, Xueshu
    Moyana, Terence
    Yang, Jicheng
    Xiang, Jim
    CELLULAR & MOLECULAR IMMUNOLOGY, 2007, 4 (04) : 277 - 285
  • [6] Influence of aging on calcium signals and cytotoxicity in murine CD8+ T cells
    Lis, A.
    Angenendt, A.
    Steiner, R.
    Zoephel, D.
    Mansion, M.
    Knoerck, A.
    Schwaerd, G.
    Krause, E.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 193 - 193
  • [7] TNF-α synthesis is differentially regulated by NFATc1 and NFATc2 in T cells
    Kaminuma, Osamu
    Kitamura, Fujiko
    Kitamura, Noriko
    Miyatake, Shoichiro
    Hiroi, Takachika
    FASEB JOURNAL, 2008, 22
  • [8] Functional analysis of bovine CD8+ and CD8+ γδ T cells
    Meissner, N
    Wilson, E
    Jackiv-Turk, L
    Jutila, M
    FASEB JOURNAL, 2000, 14 (06): : A986 - A986
  • [9] Notch controls generation and function of human effector CD8+ T cells
    Kuijk, Loes M.
    Verstege, Marleen I.
    Rekers, Niels V.
    Bruijns, Sven C.
    Hooijberg, Erik
    Roep, Bart O.
    de Gruijl, Tanja D.
    van Kooyk, Yvette
    Unger, Wendy W. J.
    BLOOD, 2013, 121 (14) : 2638 - 2646
  • [10] Averted NFATc1 Sumoylation in Alloreactive T cells Ameliorates aGVHD
    Qureischi, M.
    Dietz, L.
    Vaeth, M.
    Mottok, A.
    Beilhack, A.
    Berberich-Siebelt, F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 15 - 15